We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02053636
Brief Title: A Phase II Trial Testing Oral Administration of Lucitanib in Patients With Fibroblast Growth Factor Receptor (FGFR)1-amplified or Non-amplified Estrogen Receptor Positive Metastatic Breast Cancer (FINESSE)

First Submitted : January 24, 2014
First Submitted that Met QC Criteria : January 31, 2014
First Posted : February 4, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : January 2, 2020
Last Update Posted : January 3, 2020